Daily Trade

Biotech stocks have been through an extended lean patch, making them ideal candidates for a strong rebound. Verrica (VRCA): Approval of its viral skin disease treatment could transform the company into a commercial-stage biopharma. Amicus (FOLD): Pompe disease treatment approval opens up huge market opportunity for the biopharma. Athersys (ATHX): Potential approval for Japanese licensee
0 Comments
Novavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated, demand for Novavax’s vaccine is likely to be weak. Rival pharmaceutical companies Pfizer and Moderna have beat Novavax to market with multiple Covid-19 treatments. Source: rarrarorro / Shutterstock.com Any hope
0 Comments
The number of zombie companies ebbs and flows with economic cycles and usually increases during recessionary periods. Diebold Nixdorf (DBD): The ATM machines business contributes to top-line growth as customers increasingly shift toward automation and self-service. Mattel (MAT): The toy company plans to produce more than a dozen movies, including the highly anticipated Barbie movie in 2023.
0 Comments
Americans still hold onto the dream of homeownership — but rising prices are giving them pause. A new poll from Gallup found that only 30% of Americans believe now is a good time to buy a house. It’s the lowest level on record since Gallup began surveying Americans on this question beginning in 1978, and
0 Comments
The 148th Kentucky Derby will take place on Saturday in Louisville, Ky., and the anticipation is growing. The Kentucky Derby is known as the premier event in horse racing, as it comes with high payouts for the winner, huge fan interest and perhaps most important, famously flamboyant outfits and hats from its attendees. Here’s everything
0 Comments
You may want to put a bit more money aside for mom’s carnations this Sunday. Because, just like everything else, flowers are getting more expensive.  For Mother’s Day on May 9, the National Federation of Retailers, a trade organization, predicts that people will spend up to $31.7 billion, up 12% on last year. The group
0 Comments
EV upstart Lucid Motors (NASDAQ:LCID) delivered a strong earnings beat with its first-quarter results. Investors were lackadaisical, though, as LCID stock shed close to 12% of its value on its post-earnings sell-off. Analysts were expecting the EV firm to lose 31 cents per share on sales of $55.6 million. However, actual results came in significantly
0 Comments